Home FDA declines expanded approval for Bristol-Myers' Opdivo drug
 

Keywords :   


FDA declines expanded approval for Bristol-Myers' Opdivo drug

2015-11-28 01:31:21| Biotech - Topix.net

REUTERS: Bristol-Myers Squibb Co said the U.S. Food and Drug Administration declined to approve its immuno-oncology drug, Opdivo, for its expanded use to treat an additional type of advanced skin cancer. Bristol-Myers said it received a so-called complete response letter from the health regulator, which indicated the need for additional data in the BRAF mutated patient population.

Tags: drug expanded approval fda

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
25.06Atlantic Tropical Weather Outlook
25.06Eastern North Pacific Tropical Weather Outlook
25.06Will there be more air travel chaos this summer?
25.06Bankruptcy trustee plans to shut down Alex Jones' Infowars
25.06Eastern North Pacific Tropical Weather Outlook
25.06Atlantic Tropical Weather Outlook
25.06The screen tech that can do almost anything
25.06Criminal charges recommended against Boeing
More »